Comparative A1 vs A2 Formula & Breast Feeding on Alimentation &

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

This pilot study primarily aimed to compare effects of breast feeding, A1 versus A2®cow milk based formula on alimentation and gastrointestinal digestion. The impact of the study products on fecal myeloperoxidase (MPO), short-chain fatty acid (SCFA), secretory immunoglobulin A (sIgA) concentration, gastrointestinal tolerance, defecating habit and infant growth were also evaluated.

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06082726` - The Systemic Concentration of Short-Chain Fatty Acids After Delivery in the Small and Large Intestine of Healthy Volunteers	N/A
Withdrawn	`NCT01246492` - The Effect of Artificial Sweeteners on Blood Glucose Response	N/A
Completed	`NCT02083627` - A Study to Assess the Effects of Multiple Doses of Fidaxomicin on a Single Dose of Rosuvastatin in Healthy Male Subjects	Phase 1

NCT number	NCT03081936
Study type	Interventional
Source	a2 Milk Company Ltd.
Contact
Status	Completed
Phase	Phase 4
Start date	November 2015
Completion date	February 2016

Comparative A1 vs A2 Formula and Breast Feeding on Alimentation and Gastrointestinal Digestion for the Infant

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms